GLP-1 users often report increased interest in protein shakes, electrolytes, multivitamins, collagen supplements, and digestive health products
however, the efficacy of most drugs has not yet been proven (ClinicalTrials.gov database of COVID-19 interventional studies)
The association between the dosage of SGLT2 inhibitor and weight reduction in type 2 diabetes patients: a meta-analysis
First-in-human evaluation of oral denatonium acetate (ARD-101), a potential bitter taste receptor agonist: a randomized, double-blind, placebo-controlled phase 1 trial in healthy adults
While tirzepatide carries an established safety profile from large randomized trials, the combination with HCG remains outside mainstream clinical consensus and requires careful monitoring of appetite, weight trajectory, metabolic labs, and any adverse effects